Key result
Review summarizes current recommendations and bleeding concerns for periprocedural anticoagulation during interventional pain management.
Why the study?
Despite existing guidelines on periprocedural anticoagulant therapy, decision-making difficulties remain in interventional pain management as the treated population grows and new drugs emerge.
How should anticoagulant and antiaggregant therapy be managed periprocedurally in patients undergoing interventional pain management to minimize hemorrhagic complications?
How should anticoagulant and antiaggregant therapy be managed periprocedurally in patients undergoing interventional pain management to minimize hemorrhagic complications?
This review summarizes existing recommendations for the periprocedural management of anticoagulants and antiaggregants to mitigate bleeding risks during interventional pain procedures.
Persistent decision-making challenges in periprocedural anticoagulation for interventional pain procedures warrant individualized assessment; leaves open need for procedure-specific prospective data.
Interventional pain management bears a significant risk of hemorrhagic complications. This risk increases in patientswith coagulation disorders and those taking anticoagulant therapy. The population of the latter is growing, and manynew drugs and new treatment regimens have become widespread in recent years. The latest guidelines on the periproceduraluse of anticoagulant therapy also apply to regional anaesthesia techniques for the treatment of chronicand acute pain. However, despite the existence of guidelines and recommendations, decision-making difficultiescan still be encountered in the practice of interventional pain management. The presentation includes a summaryof existing recommendations for the prophylactic use of anticoagulants and antiaggregants in clinical practice inthe periprocedural period. Also included is a discussion of selected concerns regarding their use in the practice ofinterventional pain management.
No takes yet. Share an insight, caveat, or question.
Górniewski et al. (2023) conducted a review in Patients undergoing interventional pain management on anticoagulant therapy. Anticoagulant and antiaggregant therapy was evaluated. This review summarizes existing recommendations and discusses selected concerns regarding the prophylactic use of anticoagulants and antiaggregants during interventional pain management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: